If the goal is related to muscles, tendons, ligaments, or joints, a provider may discuss injectable BPC-157 because it does not have to pass through digestion first
That determination is not bound by the committee's vote but the agency has historically aligned with clear PCAC consensus
Mechanism involves NO system modulation (homeostatic regulationupregulating when deficient, moderating when excessive), VEGF/VEGFR2 upregulation for angiogenesis, FAK-paxillin pathway activation for cell migration (40% increase per Chang et al.), and EGR-1 transcription factor upregulation for growth factor sensitivity
An oral research formulation combining Pentadeca Arginate, Ac-SDKP and PEA in a two-stage delivery system
A clinician determines how these peptides are used based on your injury history, symptoms, and recovery goals
Target: 68 mg weekly (standard)